Clinical Trials · NCT01779362
RISE Adult Medication Study
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- RISE Study Group
- Enrollment
- 267
- Start date
- Apr 2013
- Locations
- 4 sites, United States
- Primary endpoint
- ß-cell Response Measured by Hyperglycemic Clamp